Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.223 USD | -1.35% | +2.79% | +21.11% |
May. 15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
May. 14 | Passage Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.11% | 76.43M | |
+16.78% | 123B | |
+13.05% | 107B | |
-6.07% | 24.01B | |
+1.40% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-12.69% | 16.23B | |
+2.13% | 13.43B | |
+22.97% | 11.32B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Transcript : Passage Bio, Inc. - Special Call